Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Collet

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annales De Biologie Clinique|September 19, 2024
[SFBC Working Group on sources of errors in laboratory medicine: objectives and key areas of work]Mustapha Zendjabil, Hichem Assami, Valéry Bourbonneux, et al.
Biomed Research International|June 27, 2014
Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinomaGrégory Verhoest, Thibault Dolley-Hitze, Florence Jouan, et al.
Therapeutic Drug Monitoring|September 17, 2020
Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal FunctionFlorian Lemaitre, Camille Tron, Thomas Renard, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annales De Biologie Clinique|September 19, 2024
[SFBC Working Group on sources of errors in laboratory medicine: objectives and key areas of work]Mustapha Zendjabil, Hichem Assami, Valéry Bourbonneux, et al.
Biomed Research International|June 27, 2014
Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinomaGrégory Verhoest, Thibault Dolley-Hitze, Florence Jouan, et al.
Therapeutic Drug Monitoring|September 17, 2020
Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal FunctionFlorian Lemaitre, Camille Tron, Thomas Renard, et al.
Pageof 2